eISSN: 2354-0265
ISSN: 2353-6942
Health Problems of Civilization Physical activity: diseases and issues recognized by the WHO
Current issue Archive Online first About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
Share:
Share:
abstract:
Review paper

ALLERGIC RHINITIS TREATMENT: OVERVIEW OF THE LATEST GUIDELINES

Julia Koćwin
1
,
Jakub Kordialik
2
,
Sandra Sarnacka
3
,
Paula Bieganek
1
,
Bartosz Sadłowski
1
,
Stanisław Łukaszewicz
1
,
Piotr Pawłowski
4
,
Julia Rybak
5
,
Michał Tokarski
6
,
Angelika Tokarska
7

  1. Military Medical Academy Memorial Teaching Hospital of the Medical University of Lodz, Central Veteran Hospital, Lodz, Poland
  2. Karol Jonscher Municipal Medical Center, Lodz, Poland
  3. Mikolaj Pirogow Provincial Specialist Hospital, Lodz, Poland
  4. S. Zeromski Specialist Hospital in Cracow, Poland
  5. Faculty of Medicine, Medical College, Jagiellonian University, Cracow, Poland
  6. Maria Skłodowska-Curie Specialist Hospital in Brzeziny, Poland
  7. Nicolaus Copernicus Specialist Hospital, Lodz, Poland
Health Prob Civil.
Online publish date: 2024/09/05
View full text Get citation
 
PlumX metrics:
Allergic rhinitis (AR) is a prevalent atopic disease in Poland, affecting approximately 25% of the adult population. It is characterized by chronic inflammation induced by IgE-dependent reactions to environmental allergens, leading to symptoms such as nasal congestion, sneezing, itching, and ocular manifestations. AR can be categorized as intermittent or persistent based on symptom duration and frequency. Common allergens include dust mites, pollen, animal secretions, and occupational agents. AR often coexists with asthma, necessitating accurate diagnosis and treatment to prevent bronchial complications. Diagnosis of AR relies on clinical symptoms and diagnostic tests such as skin prick testing and immunological assays. Skin prick testing is particularly useful in identifying IgE-mediated processes and guiding allergen avoidance and treatment decisions. Pharmacotherapy options include oral antihistamines and intranasal corticosteroids, with combination therapies showing promising results. Immunotherapy, in the form of subcutaneous or sublingual administration, aims to induce immunological tolerance and alleviate symptoms. In conclusion, effective management of AR involves a multifaceted approach, including allergen avoidance, pharmacotherapy, and immunotherapy. Early intervention and personalized treatment strategies are crucial for improving patient outcomes and quality of life.
keywords:

intranasal H1-antihistamine, intranasal corticosteroids, oral antihistamines, specific immunotherapy, allergic rhinitis


Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.